News

Our inaugural Top Ten Discoveries and Impacts Showcase highlighted some of the most extraordinary achievements from the University’s research ecosystem in 2025.

Monash University has entered into a licensing agreement with CSL, marking a significant outcome that reflects the University’s ambition and growing success in research translation and industry engagement.

Monash University and Ono Pharmaceutical Co., Ltd. (Ono) have signed two licence agreements that will enable Ono to develop and commercialise anti-GPCR antibodies.

Monash University has appointed Dr Ruth Park-Jones as Senior Director, Commercialisation within the Deputy Vice-Chancellor (Research and Enterprise) portfolio.

Monash University and argenx have signed a strategic partnership to advance a pioneering molecule for autoimmune diseases.

Monash University spinout RAGE Biotech has raised $29 million in Series A funding.

Researchers from the Monash Neuromedicines Discovery Centre, have been awarded the 2025 Australian Financial Review Research Commercialisation Award, for their work in creating  two Monash University spinouts.

Monash University has unveiled Monash Ventures, a new identity that unifies its venture and investment activities under a single, strategic banner.

The Monash Innovation 2024 Year in Review Report is now available, highlighting another exciting year of growth and development through research translation and innovation.